On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Agilent Technologies (Belgium)

InstitutionResearch output, impact & collaborations

Agilent Technologies (Belgium) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Agilent Technologies (Belgium)?

ScholarIQrecord summary

Agilent Technologies (Belgium) is a research organisation in Diegem, Belgium. OpenAlex records 116 works and 4,170 citations for it. 2 researchers list it as their most recent affiliation.

How many works does Agilent Technologies (Belgium) have?

ScholarIQindexed works

Agilent Technologies (Belgium) has 116 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Agilent Technologies (Belgium) have?

ScholarIQcitation count

Agilent Technologies (Belgium) has 4,170 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Agilent Technologies (Belgium)?

ScholarIQresearcher count

Agilent Technologies (Belgium) has 2 researchers in the ScholarIQ index.

What is the average h-index at Agilent Technologies (Belgium)?

ScholarIQavg h-index

Agilent Technologies (Belgium) has an average h-index of 46.5 in OpenAlex.

What is the ROR of Agilent Technologies (Belgium)?

ScholarIQror

The ROR for Agilent Technologies (Belgium) is on the source record.

What is the OpenAlex record for Agilent Technologies (Belgium)?

ScholarIQopenalex

The OpenAlex for Agilent Technologies (Belgium) is on the source record.

Who are the most-cited researchers behind Agilent Technologies (Belgium)?

ScholarIQtop researchers by citations
1
Jurgen Del‐Favero · Genetic Associations and Epidemiology
254 works18,297 citations
2
Karolien Bettens · Alzheimer's disease research and treatments
61 works18,077 citations

What are the most-cited papers on Agilent Technologies (Belgium)?

ScholarIQmost cited works
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Jean‐Charles Lambert, Simon Heath, Gaël Even, Dominique Campion, Kristel Sleegers, Mikko Hiltunen, Onofre Combarros, Diana Zélénika, María J. Bullido, Béatrice Tavernier, Luc Letenneur, Karolien Bettens, Claudine Berr, Florence Pasquier, Nathalie Fiévet, Pascale Barberger‐Gateau, Sebastiaan Engelborghs, Peter Paul De Deyn, Ignacio Mateo, A. Franck, Seppo Helisalmi, Elisa Porcellini, Olivier Hanon, Marian M. de Pancorbo, Corinne Lendon, Carole Dufouil, Céline Jaillard, Thierry Léveillard, Victoria Álvarez, Paolo Bosco, Michelangelo Mancuso, Francesco Panza, Benedetta Nacmias, Paola Bossù, Paola Piccardi, Giorgio Annoni, Davide Seripa, Daniela Galimberti, Didier Hannequin, Federico Licastro, Hilkka Soininen, Karen Ritchie, Hélène Blanché, Jean‐François Dartigues, Christophe Tzourio, Marta Gut, Christine Van Broeckhoven, Annick Alpérovitch, Mark Lathrop, Philippe Amouyel
Nature Genetics. 20092,281 CitationsOPEN ACCESS
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Lieve Claes, Jurgen Del‐Favero, Berten Ceulemans, Lieven Lagae, Christine Van Broeckhoven, Peter De Jonghe
The American Journal of Human Genetics. 20011,289 CitationsOPEN ACCESS
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
Diether Lambrechts, Erik Storkebaum, Masafumi Morimoto, Jurgen Del‐Favero, Frederik Desmet, Stefan L. Marklund, Sabine Wyns, Vincent Thijs, Jörgen Andersson, Ingrid van Marion, Ammar Al‐Chalabi, Stéphanie Bornes, Rhiannon Musson, Valerie K. Hansen, L. Beckman, Rolf Adolfsson, Hardev Pall, Hervé Prats, Séverine Vermeire, Paul Rutgeerts, Shigehiro Katayama, Takuya Awata, Nigel Leigh, Loı̈c Lang-Lazdunski, Mieke Dewerchin, Christopher E. Shaw, Lieve Moons, Robert Vlietinck, Karen Morrison, Wim Robberecht, Christine Van Broeckhoven, Désiré Collen, Peter M. Andersen, Peter Carmeliet
Nature Genetics. 2003860 CitationsOPEN ACCESS
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study
Ilse Gijselinck, Tim Van Langenhove, Julie van der Zee, Kristel Sleegers, Stéphanie Philtjens, Gernot Kleinberger, Jonathan Janssens, Karolien Bettens, Caroline Van Cauwenberghe, Sandra Pereson, Sebastiaan Engelborghs, Anne Sieben, Peter De Jonghe, Rik Vandenberghe, Patrick Santens, Jan De Bleecker, Githa Maes, Veerle Bäumer, Lubina Dillen, Geert Joris, Ivy Cuijt, Ellen Corsmit, Ellen Elinck, Jasper Van Dongen, Steven Vermeulen, Marleen Van den Broeck, C Vaerenberg, Maria Mattheijssens, Karin Peeters, Wim Robberecht, Patrick Cras, Jean‐Jacques Martin, Peter P. De Deyn, Marc Cruts, Christine Van Broeckhoven
The Lancet Neurology. 2011632 Citations
Mutations in SEPT9 cause hereditary neuralgic amyotrophy
Gregor Kuhlenbäumer, Mark Hannibal, Eva Nelis, Anja Schirmacher, Nathalie Verpoorten, Jan Meuleman, Giles D. Watts, Els De Vriendt, Peter Young, Florian Stögbauer, Hartmut Halfter, Joy Irobi, D. Goossens, Jurgen Del‐Favero, Benjamin G Betz, Hyun Hor, G. Kurlemann, Thomas D. Bird, Eila Airaksinen, Tarja Mononen, Adolfo Pou Serradell, J M Prats, Christine Van Broeckhoven, Peter De Jonghe, Vincent Timmerman, E B Ringelstein, Phillip F. Chance
Nature Genetics. 2005266 Citations

How much of the research on Agilent Technologies (Belgium) is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
20%
Hybrid
0%
Bronze
40%
Closed
40%
470M+ articles · free account